Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
A prospective multicenter surveillance program on yeast bloodstream infections was implemented in the Paris, France, area without restrictions on ward of hospitalization (intensive care unit, hematology, and surgery) or age (adults and children). The present analysis concerns 2,618 isolates collected over 7 years from 2,441 patients. Centralized species identification and antifungal susceptibility testing using the EUCAST methodology were performed. Almost 10% (232/2,441) of the patients had recently (≤30 days) been treated with antifungal drugs. We analyzed the effect of recent exposure to fluconazole ( n = 159) or caspofungin ( n = 61) on the proportions of the five major Candida species. For both drugs, preexposure was associated with a decreased prevalence of Candida albicans in favor of less drug-susceptible species ( C. glabrata and C. krusei for the former and C. parapsilosis and, to a lesser extent, C. glabrata and C. krusei for the latter; P = 0.001). In the multivariate analysis, the risk of being infected with an isolate with decreased susceptibility to fluconazole was independently associated with an age of ≥15 years (odds ratio [OR] = 2.45; 95% confidence interval [CI] = 1.39 to 4.31; P = 0.002) and with recent exposure to fluconazole (OR = 2.17; 95% CI = 1.51 to 3.13; P < 0.001), while the risk of being infected with an isolate with decreased susceptibility to caspofungin was independently associated with an age <15 years (OR = 2.53; 95% CI = 1.43 to 4.48; P = 0.001) and with recent exposure to caspofungin (OR = 4.79; 95% CI = 2.47 to 9.28; P < 0.001). These findings could influence future recommendations for the management of candidemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Of note, Candida spp. distribution may not vary only between geographical regions, but even between medical centers in close proximity, perhaps affected by factors influencing local epidemiology including prior antifungal exposure and patient age within the ICU.67”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [67]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recent exposure to an echinocandin was found to significantly increase the risk of infection with C. parapsilosis [85].”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [85]
In the citing paper
“Often, for naturally susceptible species, both the relative amount of resistant strains and the overall MIC levels in clinical isolates increase after the continuous use of a given antifungal drug [44].”
From Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens (2018) · cites this paper as [44]
In the citing paper
“Quite soon after the introduction of the echinocandins it was noted that the increasing use was accompanied by epidemiological shifts with a proportional or numeric increase in the less susceptible C. parapsilosis at several centres (8;17;18).”
From Echinocandin resistance: an emerging clinical problem? (2014) · cites this paper as [8]
In the citing paper
“A consequence of enhanced drug exposure is increased selection pressure for resistance and indeed an altered species distribution for invasive infections has been linked to the echinocandin use (8).”
From Echinocandin resistance: an emerging clinical problem? (2014) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 4×
“ysis of susceptibility profiles can occur (30).”
BackgroundResultInfluentialInternational Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Vincent, J.-L. (2009) · JAMA · doi:10.1001/jama.2009.1754 · Cited by 3,618
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191 · cited 1×
“The 2009 updated guidelines of the Infectious Diseases Society of America (IDSA) recommend that an echinocandin or fluconazole be used as first-line therapy for candidemia before identification of the causative species in nonneutropenic patients (27) and that an echinocandin be used in the case of exposure to fluconaz…”
BackgroundPosaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
Cornely, O. A., Maertens, J., Winston, D. J., Perfect, J., Ullmann, A. J., Walsh, T. J., Helfgott, D., Holowiecki, J., Stockelberg, D., Goh, Y.-T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061094 · Cited by 1,813
Guidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440 · cited 1×
“caspofungin or fluconazole, the two major drugs recommended for the first-line treatment of candidemia and for preemptive/ prophylactic treatment in high-risk patients, was associated with changes in the epidemiology of the infection (22, 28).”
BackgroundPosaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
Ullmann, A. J., Lipton, J. H., Vesole, D. H., Chandrasekar, P., Langston, A., Tarantolo, S. R., Greinix, H., Morais de Azevedo, W., Reddy, V., Boparai, N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061098 · Cited by 1,345
Horn, D. L., Neofytos, D., Anaissie, E. J., Fishman, J. A., Steinbach, W. J., Olyaei, A. J., Marr, K. A., Pfaller, M. A., Chang, C., & Webster, K. M. (2009) · Clinical Infectious Diseases · doi:10.1086/599039 · Cited by 956 · cited 1×
“In addition, they have been associated with reduced survival in cancer patients with recent azole administration (17, 38, 45).”
BackgroundWingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E., & Saral, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251803 · Cited by 937 · cited 2×
“krusei) to fluconazole is observed in hematology populations receiving prolonged fluconazole prophylactically (24, 46) as well as in ICU populations (6, 33).”
BackgroundCandida parapsilosis, an Emerging Fungal Pathogen
Trofa, D., Gácser, A., & Nosanchuk, J. D. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00013-08 · Cited by 854
The Epidemiology of Hematogenous Candidiasis Caused by Different Candida Species
Abi‐Said, D., Anaissie, E., Uzun, O., Raad, I., Pinzcowski, H., & Vartivarian, S. (1997) · Clinical Infectious Diseases · doi:10.1086/513663 · Cited by 755 · cited 1×
“The relationship between the increased incidence of these species and fluconazole prescription has been debated ever since the introduction of fluconazole as prophylaxis in hematology wards (1, 15, 33, 46) and in ICUs (14).”
Background
Research works printed but not linked: 1
- Timsit, J., H. Dupont, J. Stahl, A. Tabah, O. Lortholary, C. Martin, A. Francais, B. Guidet, and E. Azoulay. 2009. Use of anitfungal therapy in ICU: a prevalent cohort study in 169 ICUs, abstr. M-1033/523. Abstr. 49th Intersci. Conf. Antimicrob. Chemother. American Society for Microbiology, Washington, DC.
Cited by
Items 201–300 of 402
Aziz, H. S. A., Ismail, D. K., Mohammed, N. N., Elgendy, M. O., & Bassiouny, D. M. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-10007-w · Cited by 17
Szarvas, J., Rebelo, A. R., Bortolaia, V., Leekitcharoenphon, P., Hansen, D. S., Nielsen, H. L., Nørskov‐Lauritsen, N., Kemp, M., Røder, B. L., Møller, J. K., et al. (2021) · Journal of Fungi · doi:10.3390/jof7110962 · Cited by 16
Papadimitriou‐Olivgeris, M., Spiliopoulou, A., Fligou, F., Spiliopoulou, I. T., Tanaseskou, L., Karpetas, G., Marangos, M. N., Anastassiou, E. D., & Christofidou, M. (2017) · Infection · doi:10.1007/s15010-017-1050-z · Cited by 18
Mixed fungaemia: an 18-year report from a tertiary-care university hospital and a systematic review
Gülmez, D., Alp, Ş., Gürsoy, G., Ayaz, Ç. M., Doğan, Ö., Arıkan-Akdağlı, S., & Akova, M. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.03.030 · Cited by 16
Weekly use of fluconazole as prophylaxis in haematological patients at risk for invasive candidiasis
Vuichard, D., Weisser, M., Orasch, C., Frei, R., Heim, D. A., Passweg, J. R., & Widmer, A. F. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0573-5 · Cited by 15
Huston, J. M., Kreiner, L. A., Ho, V. P., Sanders, J. M., & Duane, T. M. (2019) · Surgical Infections · doi:10.1089/sur.2019.062 · Cited by 15
Ryan, P., Motherway, C., Powell, J., Elsaka, A., Sheikh, A., Jahangir, A., O’Connell, N. H., & Dunne, C. P. (2019) · Journal of Hospital Infection · doi:10.1016/j.jhin.2019.01.017 · Cited by 15
BASES DA RESISTÊNCIA ANTIFÚNGICA: UMA REVISÃO COMENTADA
Berto, C., Wirth, F., Barth, N., & Hermes, D. M. (2018) · Revista Uningá · doi:10.46311/2318-0579.55.euj773 · Cited by 15
Comparison of MALDI‐TOF mass spectra with microsatellite length polymorphisms in Candida albicans
Dhieb, C., Normand, A., L’Ollivier, C., Gautier, M., Vranckx, K., Euch, D. E., Chaker, E., Hendrickx, M., Dalle, F., Sadfi‐Zouaoui, N., et al. (2015) · Journal of Mass Spectrometry · doi:10.1002/jms.3538 · Cited by 15
Fernández‐Silva, F., Lackner, M., Capilla, J., Mayayo, E., Sutton, D. A., Castanheira, M., Fothergill, A. W., Lass‐Flörl, C., & Guarro, J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02666-13 · Cited by 15
Awad, L. S., Tamim, H., Abdallah, D., Salameh, M. A., Mugharbil, A., Jisr, T., Zahran, K., Droubi, N., Ibrahim, A., & Moghnieh, R. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3512-z · Cited by 15
Treatment of invasive candidiasis: between guidelines and daily clinical practice
Tagliaferri, E., & Menichetti, F. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1029916 · Cited by 14
Chesdachai, S., Yetmar, Z. A., Ranganath, N., Everson, J. J., Wengenack, N. L., & Saleh, O. A. (2023) · Journal of Fungi · doi:10.3390/jof9080821 · Cited by 14
Krämer, A., Pochhammer, J., Walger, P., Seifert, U., Ruhnke, M., & Harnoss, J.-C. (2017) · Der Chirurg · doi:10.1007/s00104-017-0382-7 · Cited by 14
Systemic antifungal drug use in Belgium—One of the biggest antifungal consumers in Europe
Goemaere, B., Lagrou, K., Spriet, I., Hendrickx, M., Vandael, E., Becker, P., & Catry, B. (2019) · Mycoses · doi:10.1111/myc.12912 · Cited by 14
Polat, S. H., Sharifynia, S., Öz, Y., Aslan, M., Gündoğdu, N., Serin, A., Rafati, H., Mohammadi, F., Metin, D. Y., Döğen, A., et al. (2018) · Mycopathologia · doi:10.1007/s11046-018-0261-x · Cited by 14
Desnos-Ollivier, M., Bretagne, S., Lortholary, O., Dromer, F., & the French Mycoses Study Group N. Brieu CH Aix, T. C. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01725-21 · Cited by 13
Self-citationKhan, Z., Ahmad, S., Al‐Sweih, N., Mokaddas, E. M., Al-Banwan, K., Alfouzan, W. A., Al‐Obaid, I., Alobaid, K., & Varghese, S. (2020) · Microbial Drug Resistance · doi:10.1089/mdr.2019.0437 · Cited by 13
de Fontbrune, F. S., Denis, B., Meunier, M., Garcia‐Hermoso, D., Bretagne, S., & Alanio, A. (2014) · Transplant Infectious Disease · doi:10.1111/tid.12231 · Cited by 13
Self-citationWang, Y., Yang, Q., Chen, L., Liu, L., Hao, R., Zhang, T., Wang, X., Lei, J., Xie, J., & Dong, Y. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3034-4 · Cited by 13
Cortegiani, A., Russotto, V., Raineri, S. M., Gregoretti, C., Rosa, F. G. D., & Giarratano, A. (2017) · Current Fungal Infection Reports · doi:10.1007/s12281-017-0288-3 · Cited by 13
Dockrell, D. H., O’Shea, D., Cartledge, J. D., & Freedman, A. (2019) · HIV Medicine · doi:10.1111/hiv.12806 · Cited by 13
Brescini, L., Mazzanti, S., Orsetti, E., Morroni, G., Masucci, A., Pocognoli, A., & Barchiesi, F. (2020) · Journal of Chemotherapy · doi:10.1080/1120009x.2020.1783154 · Cited by 13
Shokohi, T., Aslani, N., Ahangarkani, F., Meyabadi, M. F., Hagen, F., Meis, J. F., Boekhout, T., Kolecka, A., & Badali, H. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.12.069 · Cited by 11
Miyazaki, T., Shimamura, S., Nagayoshi, Y., Nakayama, H., Morita, A., Tanaka, Y., Matsumoto, Y., Inamine, T., Nishikawa, H., Nakada, N., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56269-z · Cited by 11
Clinical and mycological investigations of post‐COVID ‐19 acute invasive fungal sinusitis
Eldsouky, S. M., Shahat, A. K., AL‐Tabbakh, A. M., Abdelrahman, S. M., Marei, Y. M., Mohammed, L. A., El-Shimi, O. S., Abdelmotaleb, D. S., Marei, Y. M., & Elsayed, M. S. A. E. (2022) · Laryngoscope Investigative Otolaryngology · doi:10.1002/lio2.956 · Cited by 11
Afhami, S., Adibimehr, A., Mousavi, S. A., Vaezi, M., Montazeri, M., Salehi, M., Meidani, M., Saleh, M., Ahmadikia, K., Roilides, E., et al. (2024) · International Journal of Hematology-Oncology and Stem Cell Research · doi:10.18502/ijhoscr.v18i1.14746 · Cited by 11
Rosa, F. G. D., Corcione, S., Montrucchio, G. G., Brazzi, L., & Perri, G. D. (2017) · Türk anesteziyoloji ve reanimasyon derneği dergisi · doi:10.5152/tjar.2016.0011 · Cited by 12
Lausch, K. R., Søgaard, M., Rosenvinge, F. S., Johansen, H. K., Boysen, T., Røder, B. L., Mortensen, K. L., Nielsen, L. B., Lemming, L. E., Olesen, B. R. S., et al. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s176384 · Cited by 11
Adherence and Cytotoxicity of Candida spp. to HaCaT and A549 cells
Ichikawa, T., Kutsumi, Y., Sadanaga, J., Ishikawa, M., Sugita, D., & Ikeda, R. (2019) · Medical Mycology Journal · doi:10.3314/mmj.18-00011 · Cited by 11
Candida nivariensis: Identification strategy in mycological laboratories
Cartier, N., Chesnay, A., N’diaye, D., Thorey, C., Ferreira, M., Haillot, O., Bailly, É., & Désoubeaux, G. (2020) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2020.101042 · Cited by 11
El-Salam, A. M. A., Tahoun, A. A. E., & Hanafy, N. A. N. (2023) · Food Hydrocolloids for Health · doi:10.1016/j.fhfh.2023.100136 · Cited by 11
Kovács, F., Balla, N., Bozó, A., Harmath, A., Jakab, Á., Tóth, Z., Nagy, F., Majoros, L., & Kovács, R. (2024) · Mycoses · doi:10.1111/myc.13727 · Cited by 10
Investigation of culturable human gut mycobiota from the segamat community in Johor, Malaysia
Huët, M. A. L., Wong, L. W., Goh, C. B. S., Hussain, M. H., Muzahid, N. H., Dwiyanto, J., Lee, S. W. H., Ayub, Q., Reidpath, D. D., Lee, S. M., et al. (2021) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-021-03083-6 · Cited by 10
Çağlar, İ., Devrim, İ., Özdemir, H., Şahbudak, Z., Sönmez, G., Büyükçam, A., Gülhan, B., Kara, A., Aygun, D. F., Bayram, N., et al. (2018) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2018.08.007 · Cited by 10
Pinheiro, A. M., Carreira, A., Rollo, F., Fernandes, R., Ferreira, R. B., & Monteiro, S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01803 · Cited by 10
On behalf of the French Mycoses Study Group, Desnos‐Ollivier, M., Uruguayan Invasive Fungal Infection Network, Bórmida, V., Poirier, P., Nourrisson, C., Pan, D., Bretagne, S., Puime, A., & Dromer, F. (2017) · Mycopathologia · doi:10.1007/s11046-017-0224-7 · Cited by 10
Self-citationLi, Z., Cui, Z., Xie, D., Zou, F., & Zhu, C. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1632488 · Cited by 9
Mechanisms of Resistance to Antifungal Agents
Perlin, D. S. (2015) · ASM Press eBooks · doi:10.1128/9781555817381.ch130 · Cited by 9
Lahfa-Hassaine, I., Boucherit‐Otmani, Z., Sari-Belkharroubi, L., & Boucherit, K. (2017) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2017.01.012 · Cited by 9
Longer incubation times for yeast fungemia: importance for presumptive treatment
Paugam, A., Ancelle, T., Lortholary, O., & Bretagne, S. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.05.013 · Cited by 9
Self-citationRouges, C., Asad, M., Laurent, A. D., Marchand, P., & Pape, P. L. (2023) · Microorganisms · doi:10.3390/microorganisms11122837 · Cited by 8
Prusty, J. S., Kumar, A., & Kumar, A. (2024) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2024.2418125 · Cited by 8
Harrison, M., Rinker, D. C., LaBella, A. L., Opulente, D. A., Wolters, J. F., Zhou, X., Shen, X., Groenewald, M., Hittinger, C. T., & Rokas, A. (2026) · PLoS Genetics · doi:10.1371/journal.pgen.1012091 · Cited by 8
Epidemiology of candidemia at a tertiary Canadian hospital, 2004–2013
Remington, T. L., Isaac, A., Vickers, D., Fuller, J., & Smith, S. W. (2018) · Journal of the Association of Medical Microbiology and Infectious Disease Canada · doi:10.3138/jammi.3.1.04 · Cited by 8
Murri, R., Lardo, S., Luca, A. D., Posteraro, B., Torelli, R., Angelis, G. D., Giovannenze, F., Taccari, F., Pavan, L., Parroni, L., et al. (2021) · Medicina · doi:10.3390/medicina57070656 · Cited by 8
Species Distribution and Antifungal Susceptibilities of Candida Species Isolated From Blood Culture
Cılo, B. D. (2023) · Cureus · doi:10.7759/cureus.38183 · Cited by 8
Clinical Syndromes: Candida and Candidosis
Ruhnke, M. (2018) · Springer eBooks · doi:10.1007/978-3-319-92300-0_4 · Cited by 8
Araujo, H. C., Pessan, J. P., Caldeirão, A. C. M., Sampaio, C., Oliveira, M. J. D. S., Sales, D. H., Teixeira, S. R., Constantino, C. J. L., Delbem, A. C. B., Oliveira, S. H. P., et al. (2023) · Journal of Dentistry · doi:10.1016/j.jdent.2023.104699 · Cited by 8
Puesta al día en la candidiasis invasora en el paciente crítico no neutropénico
Zaragoza, R., Ramírez, P., Borges-Sa, M., & Pemán, J. (2016) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2016.03.001 · Cited by 8
Adamu, A. A., Ntulume, I., Odda, J., & Okech, M. A. (2017) · African Journal of Microbiology Research · doi:10.5897/ajmr2017.8588 · Cited by 8
Difficult to Treat Infections in the Burn Patient
Lago, K., Decker, C. F., Chung, K. K., & Blyth, D. M. (2020) · Surgical Infections · doi:10.1089/sur.2020.128 · Cited by 8
Kayıran, S. D., TAVLI, Ö. F., Kara, E. M., Kaplan, A., Şahin, H., Boğa, M., & Özkan, E. E. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1618761 · Cited by 7
Management of invasive candidiasis in nonneutropenic ICU patients
Weiss, E., & Timsit, J. (2014) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936114562586 · Cited by 7
Ibe, C., Otu, A. A., & Pohl, C. H. (2025) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2024.2448844 · Cited by 7
Multidrug- and Cross-Resistant Candida: the Looming Threat
Lackner, M., Martín‐Vicente, A., & Lass‐Flörl, C. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0210-1 · Cited by 7
Griffin, M., Kosmisky, D. E., Templin, M. A., Huynh, T. T., McCurdy, L., Pasquale, T. R., & Martin, K. E. (2016) · Heart & Lung · doi:10.1016/j.hrtlng.2016.08.002 · Cited by 7
Yardımcı, A. C., & Arman, D. (2022) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.120801 · Cited by 7
Pech-Puch, D., Grilo, D., Calva-Pérez, S. E., Pedras, A., Villegas‐Hernández, H., Guillén-Hernández, S., Díaz-Gamboa, R. E., Forero, A. M., Rodríguez, J., Lenis-Rojas, O. A., et al. (2023) · Molecules · doi:10.3390/molecules28020606 · Cited by 6
An update on pharmacotherapy for fungal infections in allogeneic stem cell transplant recipients
Panagopoulou, P., & Roilides, E. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2387686 · Cited by 6
Épidémiologie de la résistance des champignons : impact de nos prescriptions d’antifongiques
Alanio, A., Renaudat, C., & Bretagne, S. (2014) · Journal des Anti-infectieux · doi:10.1016/j.antinf.2014.01.006 · Cited by 6
Self-citationPilmis, B., Yang, Z., Lanternier, F., & Lortholary, O. (2016) · Elsevier eBooks · doi:10.1016/b978-0-7020-6285-8.00049-6 · Cited by 6
Self-citationSumana, M., & Umamaheshwari, S. (2020) · Indian Journal of Dermatology · doi:10.4103/ijd.ijd_385_19 · Cited by 6
Empiric/pre-emptive anti-Candida therapy in non-neutropenic ICU patients
Timsit, J., Chemam, S., & Bailly, S. (2015) · F1000Prime Reports · doi:10.12703/p7-21 · Cited by 7
New Antifungal Susceptibility Test Based on Chitin Detection by Image Cytometry
Wang, Y., Andriampamonjy, A. N., Bailly, S., Garnaud, C., Maubon, D., Cornet, M., & Aldebert, D. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01101-19 · Cited by 6
Câmara, C. R. S., Shi, Q.-Y., Pedersen, M., Zbasnik, R., Nickerson, K. W., & Schlegel, V. L. (2018) · Phytotherapy Research · doi:10.1002/ptr.6222 · Cited by 6
Update on Antifungal Resistance and its Clinical Impact
Posteraro, B., Posteraro, P., & Sanguinetti, M. (2013) · Current Fungal Infection Reports · doi:10.1007/s12281-013-0143-0 · Cited by 5
Micosis sistémicas en pacientes inmunocomprometidos
Valderrama, S. O., Martínez, J. A. H., Torresb, A. H., Escudero, E. M., Gómez, J. G., & Hernández, M. S. (2018) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2018.05.003 · Cited by 5
Massanet, P. L., Jung, B., Molinari, N., Villiet, M., Moulaire, V., Roch-Torreilles, I., Jaber, S., Reynes, J., & Corne, P. (2014) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/j.annfar.2014.02.016 · Cited by 5
Aldrees, A., Ghonem, L., Almajid, F. M., Barry, M. A., Mayet, A. Y., & Almohaya, A. M. (2021) · Antibiotics · doi:10.3390/antibiotics10121498 · Cited by 5
Jainlabdin, M. H., Chua, A. L., Nizam, T. M., & Santhanam, J. (2018) · Sains Malaysiana · doi:10.17576/jsm-2018-4703-08 · Cited by 5
Épidémiologie des candidoses invasives en France
Charles, P., Large, A., Quenot, J., & Dalle, F. (2016) · Réanimation · doi:10.1007/s13546-016-1183-6 · Cited by 6
Micosis sistémicas en pacientesno inmunocomprometidos
Valderrama, S. O., Martínez, J. A. H., Torres, A. H., Escudero, E. M., Gómez, J. G., & Hernández, M. S. (2018) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2018.05.002 · Cited by 5
Fournier, P. (2011) · HAL · Cited by 5
Atividade antifúngica de Sideroxylon obtusifolium frente a diferentes espécies de Candida sp.
da Silva, R. S., de Oliveira, K. M. S., & Cavalcante, G. M. (2017) · Estação Científica (UNIFAP) · doi:10.18468/estcien.2017v7n1.p95-102 · Cited by 4
Candidemia in the intensive care unit: A 12-year retrospective cohort study in Reunion Island
Hoarau, G., Picot, S., Lemant, J., Peytral, J., Poubeau, P., Zunic, P., Mohr, C., Coueffé, X., Gérardin, P., & Antok, E. (2018) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2018.04.392 · Cited by 4
Davari, A., Jafarzadeh, J., Hedayati, M. T., Shokohi, T., Abastabar, M., Nikmanesh, B., & Moazeni, M. (2022) · Current Medical Mycology · doi:10.18502/cmm.8.2.10329 · Cited by 4
Mattsby‐Baltzer, I., Pinel, C., Marcos, J. Y., Kondori, N., Potton, L., Thiébaut, A., Pelloux, H., & Cornet, M. (2015) · Medical Mycology · doi:10.1093/mmy/myv037 · Cited by 4
Einav, S., Raveh, D., Lachish, T., Baumstarck, K., Martin, C. D., Martín‐Loeches, I., & Léone, M. (2019) · Surgical Infections · doi:10.1089/sur.2018.267 · Cited by 4
Antimicrobial stewardship in pediatric solid organ transplantation: Is it possible?
Kitano, T., & Allen, U. (2022) · Transplant Infectious Disease · doi:10.1111/tid.13928 · Cited by 4
Islam, S., Farjana, M., Uddin, M. R., Akter, S., Jabin, A., Nafisa, H. T.-Z., Siraji, S., Morshed, A. K. M. H., Rimti, F. H., Naim, Z., et al. (2022) · Journal of Advanced Veterinary and Animal Research · doi:10.5455/javar.2022.i635 · Cited by 4
BASES DA RESISTÊNCIA ANTIFÚNGICA: UMA REVISÃO COMENTADA
Berto, C., & Hermes, D. M. (2023) · Editora Científica Digital eBooks · doi:10.37885/221211599 · Cited by 4
Enfermedades invasoras por hongos levaduriformes en pacientes neutropénicos
Ruíz-Camps, I., & Jarque, I. (2016) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2015.11.001 · Cited by 4
Neonatal fungal sepsis in Jos North-Central Nigeria
Ojogba, O. M., Grace, A., Bose, T., Esther, E., Olubukunnola, I., Abel, I., Emmanuel, O., Dashe, N., Kenneth, O., Echeonwu, B., et al. (2020) · Journal of Medicine in the Tropics · doi:10.4103/jomt.jomt_29_19 · Cited by 4
Antinori, S., Milazzo, L., Sollima, S., Galli, M., & Corbellino, M. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.09.005 · Cited by 4
Joshi, D. N., Archana, M., Gor, N. S., Bhavana, M. V., Adhikary, R., & Shenoy, B. (2025) · EMJ Microbiology & Infectious Diseases · doi:10.33590/emjmicrobiolinfectdis/hkmw5127 · Cited by 3
Rabault, C., Shuping, L., Mpembe, R. S., Quan, V., Lanternier, F., Lortholary, O., Paccoud, O., Govender, N. P., & GERMS-SA, F. (2025) · Emerging infectious diseases · doi:10.3201/eid3110.250359 · Cited by 3
Self-citationMartins, N. D. G., Lucini, F., Nascimento, B. C. M., Salomé, T. M., Vasconcelos, N. G., Limiere, L. C., Silva, S. C., & Rossato, L. L. (2026) · Brazilian Journal of Microbiology · doi:10.1007/s42770-026-01933-9 · Cited by 3
Oyom, A. P., Okello, E., Acam, V., Aramo, C., Mwambi, B., Okiria, J. C., & Oyet, C. (2020) · African Journal of Laboratory Medicine · doi:10.4102/ajlm.v9i1.997 · Cited by 3
CANDIDEMIA IN CANCER PATIENTS: FEATURES OF THE TAXONOMIC STRUCTURE
Bagirova, N. S., Николаевна, П. И., & Grigorievskaya, Z. V. (2023) · Russian Clinical Laboratory Diagnostics · doi:10.51620/0869-2084-2022-67-7-399-406 · Cited by 3
Antifungal Prophylaxis in the Pediatric Intensive Care Unit
Vogiatzi, L., Katragkou, A., & Roilides, E. (2013) · Current Fungal Infection Reports · doi:10.1007/s12281-013-0154-x · Cited by 3
Nouveaux marqueurs pour le diagnostic de la maladie fongique invasive
Poissy, J., Parmentier-Decrucq, E., Sendid, B., Mathieu, D., & Poulain, D. (2014) · Réanimation · doi:10.1007/s13546-014-0866-4 · Cited by 3
ACTIVITY OF ANTIBIOTIC ROSEOFUNGIN AGAINST CLINICAL PATHOGENS OF VAGINAL CANDIDIASIS
САДАНОВ, А. К., Акылова, М. А., Balgimbaeva, A. S., Ibragimova, L., Bekezhanova, T. S., Itemirova, A. O., TURLYBAYEVA⃰, Z. Z., Sultanova, A. Z., Galimbaeva, R. S., & Trenozhnikova, L. P. (2018) · SERIES OF BIOLOGICAL AND MEDICAL · doi:10.32014/2018.2518-1629.16 · Cited by 3
Pinhati, H. M. S. (2015) · RIUnB Institutional Repository (University of Brasília) · doi:10.26512/2015.10.t.19942 · Cited by 3
Indication des traitements antifongiques (hors hématologie). Que montrent les données ?
Huette, P., & Dupont, H. (2019) · Anesthésie & Réanimation · doi:10.1016/j.anrea.2019.03.004 · Cited by 2
Probiotics in Invasive Candidiasis
Colombo, J., & Arena, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-802189-7.00048-4 · Cited by 2
Fungal infections—Background to specific fungal species
Sokóvić, M., & Λιάρας, Κ. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815824-1.00002-0 · Cited by 2
Rafie, R. A., Soflaee, M., Mortezaeian, H., Jalali, A., Feyzi, A., Anafje, M., & Soheili, A. (2025) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2025.116787 · Cited by 2
Early Recognition of Invasive Candidiasis in the ICU
Charles, P., Bruyère, R., & Dalle, F. (2012) · Springer eBooks · doi:10.1007/978-3-642-25716-2_29 · Cited by 2
Fabien, L., Foroni, L., Brion, J., Maubon, D., Stahl, J. ‐., & Pavèse, P. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2013.11.029 · Cited by 2
Metadata
- Authors
- Lortholary, O., Desnos-Ollivier, M., Sitbon, K., Fontanet, A., Bretagne, S., & Dromer, F.
- Affiliations
- Hôpital Necker-Enfants Malades (FR)
- Institut Pasteur, Unité de Mycologie Moléculaire, Centre National de Référence Mycologie et Antifongiques, Paris
- Centre National de la Recherche Scientifique (FR)
- Institut Pasteur (FR)
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2011-02
- Volume
- 55
- Issue
- 2
- Pages
- 532-538
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC3028765
- OpenAlex
- W1981025594
- Cited by
- 362
- References
- 47
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 20 · 2023: 18 · 2022: 18 · 2021: 18 · 2020: 31 · 2019: 16 · 2018: 34 · 2017: 30 · 2016: 23 · 2015: 31 · 2014: 41 · 2013: 24 · 2012: 26
- FWCI
- 11.98
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Pfizer
- Gilead Sciences
- Astellas Pharma
- Institut Gustave-Roussy
- Institut de Veille Sanitaire
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- candidemia, caspofungin, fluconazole, Candida species distribution, Candida albicans, Candida glabrata, Candida krusei, Candida parapsilosis, antifungal susceptibility, reduced susceptibility, fungemia, epidemiology
- MeSH terms
- Caspofungin, Adult, Antifungal Agents, Candida, Candida albicans, Child, Child, Preschool, Cross Infection, France, Humans, Microbial Sensitivity Tests, Paris, Population Surveillance, Prospective Studies, Species Specificity, Fluconazole, Prevalence, Drug Resistance, Fungal, Echinocandins, Lipopeptides, Candidemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.